Your browser doesn't support javascript.
loading
Amplified EPOR/JAK2 Genes Define a Unique Subtype of Acute Erythroid Leukemia.
Takeda, June; Yoshida, Kenichi; Nakagawa, Masahiro M; Nannya, Yasuhito; Yoda, Akinori; Saiki, Ryunosuke; Ochi, Yotaro; Zhao, Lanying; Okuda, Rurika; Qi, Xingxing; Mori, Takuto; Kon, Ayana; Chiba, Kenichi; Tanaka, Hiroko; Shiraishi, Yuichi; Kuo, Ming-Chung; Kerr, Cassandra M; Nagata, Yasunobu; Morishita, Daisuke; Hiramoto, Nobuhiro; Hangaishi, Akira; Nakazawa, Hideyuki; Ishiyama, Ken; Miyano, Satoru; Chiba, Shigeru; Miyazaki, Yasushi; Kitano, Toshiyuki; Usuki, Kensuke; Sezaki, Nobuo; Tsurumi, Hisashi; Miyawaki, Shuichi; Maciejewski, Jaroslaw P; Ishikawa, Takayuki; Ohyashiki, Kazuma; Ganser, Arnold; Heuser, Michael; Thol, Felicitas; Shih, Lee-Yung; Takaori-Kondo, Akifumi; Makishima, Hideki; Ogawa, Seishi.
Afiliação
  • Takeda J; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Yoshida K; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Nakagawa MM; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Nannya Y; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Yoda A; Division of Hematopoietic Disease Control, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Saiki R; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Ochi Y; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Zhao L; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Okuda R; Institute for the Advanced Study of Human Biology (WPI ASHBi), Kyoto University, Kyoto, Japan.
  • Qi X; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Mori T; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Kon A; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Chiba K; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Tanaka H; Division of Genome Analysis Platform Development, National Cancer Center Research Institute, Tokyo, Japan.
  • Shiraishi Y; M&D Data Science Center, Tokyo Medical and Dental University, Tokyo, Japan.
  • Kuo MC; Division of Genome Analysis Platform Development, National Cancer Center Research Institute, Tokyo, Japan.
  • Kerr CM; Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital-Linkou, Chang Gung University, Taoyuan, Taiwan.
  • Nagata Y; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio.
  • Morishita D; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio.
  • Hiramoto N; Chordia Therapeutics Inc., Kanagawa, Japan.
  • Hangaishi A; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Nakazawa H; Department of Hematology, NTT Medical Centre Tokyo, Tokyo, Japan.
  • Ishiyama K; Department of Hematology, Shinshu University Hospital, Matsumoto, Japan.
  • Miyano S; Department of Hematology, Kanazawa University, Kanazawa, Japan.
  • Chiba S; M&D Data Science Center, Tokyo Medical and Dental University, Tokyo, Japan.
  • Miyazaki Y; Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
  • Kitano T; Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan.
  • Usuki K; Japan Adult Leukemia Study Group, Japan.
  • Sezaki N; Department of Hematology, Kitano Hospital, Tazuke Kofukai Medical Research Institute, Osaka, Japan.
  • Tsurumi H; Department of Hematology, NTT Medical Centre Tokyo, Tokyo, Japan.
  • Miyawaki S; Department of Hematology, Chugoku Central Hospital, Hiroshima, Japan.
  • Maciejewski JP; Department of Hematology, Gifu University, Gifu, Japan.
  • Ishikawa T; Division of Hematology, Tokyo Metropolitan Ohtsuka Hospital, Tokyo, Japan.
  • Ohyashiki K; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio.
  • Ganser A; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Heuser M; Department of Hematology, Tokyo Medical University, Tokyo, Japan.
  • Thol F; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • Shih LY; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • Takaori-Kondo A; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • Makishima H; Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital-Linkou, Chang Gung University, Taoyuan, Taiwan.
  • Ogawa S; Department of Hematology/Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Blood Cancer Discov ; 3(5): 410-427, 2022 09 06.
Article em En | MEDLINE | ID: mdl-35839275
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Leucemia Eritroblástica Aguda / Receptores da Eritropoetina / Janus Quinase 2 Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Leucemia Eritroblástica Aguda / Receptores da Eritropoetina / Janus Quinase 2 Idioma: En Ano de publicação: 2022 Tipo de documento: Article